Ceryvyn Therapeutics-ADRCYVNY
13F holders, Q1 2025 (March 31)9holders −2
1new positions
3sold out
1famous investor
$0.08avg. 13F price*
At the end of Q1 2025, 9 institutions reported holding Ceryvyn Therapeutics-ADR (CYVNY) in their 13F filings, down 2 from Q4 2024. 1 opened new positions and 3 sold out. The largest holders were HSBC Holdings PLC ($356K), Twin Lakes Capital Management, LLC ($113K) and Millennium Management ($81K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Ceryvyn Therapeutics-ADR
- Filed as
- OPTHEA LTD (Q1 2025)
- CUSIP
- 68386J208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $34K |
| Exits | 3 | $168K |
All 13F filers, Q4 2024 → Q1 2025: 2,318,074 shares bought and 209,759 shares sold, net +2,108,315 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| HSBC Holdings PLC | 0.00% | Reduce -25.7% | 105,939 | $356K |
| Twin Lakes Capital Management, LLC | 0.08% | Add +67.4% | 33,156 | $113K |
| Millennium Management | 0.00% | Reduce -20.9% | 48,329 | $81K |
| EP Wealth Advisors, LLC | 0.00% | New | 10,000 | $34K |
| UBS Group AG | 0.00% | Reduce -78.8% | 7,773 | $27K |
| Morgan Stanley | 0.00% | Reduce -77.3% | 765 | $3K |
| Baker Bros. Advisors LP | 0.00% | Reduce -4.0% | 2,087,320 | $0 |
| Old Mission Capital LLC | 0.00% | Add +78.7% | 19,167 | $0 |
| Regal Partners Ltd | 0.00% | Add +78.6% | 5,193,688 | $0 |
"% of holder's portfolio" is CYVNY's weight in each manager's 13F, not the share of Ceryvyn Therapeutics-ADR the manager owns.